(Q43038413)

12 November 2017

title

Alcohol abstinence does not offset the strong negative effect of lifetime alcohol consumption on the outcome of interferon therapy (English)

1 reference

12 November 2017

0 references

Tabone M

1

1 reference

12 November 2017

Sidoli L

2

1 reference

12 November 2017

Laudi C

3

1 reference

12 November 2017

Pellegrino S

4

1 reference

12 November 2017

Rocca G

5

1 reference

12 November 2017

Della Monica P

6

1 reference

12 November 2017

Fracchia M

7

1 reference

12 November 2017

Galatola G

8

1 reference

12 November 2017

Molinaro GC

9

1 reference

12 November 2017

Aricò S

10

1 reference

12 November 2017

Pera A

11

1 reference

12 November 2017

publication date

1 July 2002

1 reference

Journal of Viral Hepatitis

12 November 2017

published in

1 reference

12 November 2017

volume

9

1 reference

12 November 2017

issue

4

1 reference

12 November 2017

page(s)

288-294

1 reference

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00360.X

Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00360.X

Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00360.X

Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00360.X

Review article: interferon and hepatitis C--factors predicting therapeutic outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00360.X

Efficacy of interferon therapy in patients with chronic hepatitis C. Comparison between non-drinkers and drinkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00360.X

Drinking habits of subjects with hepatitis C virus-related chronic liver disease: prevalence and effect on clinical, virological and pathological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00360.X

Targeting of drugs to the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00360.X

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00360.X

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00360.X

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00360.X

Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00360.X

Hepatitis C viremia and anti-HCV antibodies in alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00360.X

Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00360.X

The treatment of chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00360.X

Monitoring oxidative damage in patients with liver cirrhosis and different daily alcohol intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00360.X

Plasma membrane hydroxyethyl radical adducts cause antibody-dependent cytotoxicity in rat hepatocytes exposed to alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00360.X

Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00360.X

Interferon for non-A, non-B chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00360.X

10.1046/J.1365-2893.2002.00360.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference